Center for Scientific Review; Notice of Closed Meetings, 12196 [2021-04229]
Download as PDF
<![CDATA[
12196
Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Medicine Board of Scientific
Counselors.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for review, discussion, and evaluation of
individual intramural programs and
projects conducted by the NATIONAL
LIBRARY OF MEDICINE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Board of Scientific Counselors.
Date: April 22, 2021.
Open: April 22, 2021, 11:00 a.m. to 12:30
p.m.
Agenda: Program Discussion and Senior
Investigator Report.
Place: Virtual Meeting.
Closed: April 22, 2021, 12:30 p.m. to 12:45
p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: April 22, 2021, 12:45 p.m. to 3:45
p.m.
Agenda: Senior Investigator Report.
Closed: April 22, 2021, 3:45 p.m. to 4:15
p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Contact Person: Valerie Florance, Ph.D.,
Acting Scientific Director, National Library of
Medicine, National Institutes of Health, 6705
Rockledge Drive, Suite 500, Bethesda, MD
20892, 301–496–6221, floranc@mail.nih.gov.
Any member of the public may submit
written comments no later than 15 days after
the meeting. Any interested person may file
written comments with the committee by
forwarding the statement to the Contact
Person listed on this notice. The statement
should include the name, address, telephone
number and when applicable, the business or
professional affiliation of the interested
person.
Open sessions of this meeting will be
broadcast to the public, and available for
viewing at https://videocast.nih.gov on April
22, 2021. Please direct any questions to the
Contact Person listed on this notice.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
VerDate Sep<11>2014
17:11 Mar 01, 2021
Jkt 253001
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04225 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Cognitive and Neuropathological
signatures of Alzheimer’s Disease, Brain
Injury and Aging.
Date: March 23, 2021.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders.
Date: March 23–24, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846 Bethesda, MD 20892 301–435–
1259 nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; Member
Conflict: Child Psychopathology,
Developmental Disabilities, and Mechanisms
of Anxiety and Depression.
Date: March 25, 2021.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848 Bethesda, MD
20892, (301) 402–4411 tianbi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Antiviral Therapeutics.
Date: March 29–30, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Bethesda, MD
20894 301–435–4057 bidyottam.mittra@
nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Dermatology Development and
Disease.
Date: March 29, 2021.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814 Bethesda, MD 20892, (301) 496–
8551 ingrahamrh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04229 Filed 3–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be held as a virtual
meeting and is open to the public.
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 86, Number 39 (Tuesday, March 2, 2021)]
[Notices]
[Page 12196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04229]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Cognitive and Neuropathological signatures of
Alzheimer's Disease, Brain Injury and Aging.
Date: March 23, 2021.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D., Chief, BDCN IRG,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846 Bethesda, MD 20892, (301) 435-
1246, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Fogarty Global Brain Disorders.
Date: March 23-24, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846 Bethesda, MD 20892 301-435-
1259 [email protected].
Name of Committee: Center for Scientific Review, Special
Emphasis Panel; Member Conflict: Child Psychopathology,
Developmental Disabilities, and Mechanisms of Anxiety and
Depression.
Date: March 25, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3089B, MSC 7848 Bethesda, MD 20892, (301) 402-
4411 [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Antiviral Therapeutics.
Date: March 29-30, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Bethesda, MD 20894 301-435-4057
[email protected]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member conflict: Dermatology Development and Disease.
Date: March 29, 2021.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814 Bethesda, MD
20892, (301) 496-8551 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 24, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04229 Filed 3-1-21; 8:45 am]
BILLING CODE 4140-01-P
